National Gaucher Foundation - Gaucher Disease
Slideshow Image 1
Slideshow Image 2
Slideshow Image 3

Gaucher Disease News at a Glance

Nov 21, 2014 - European CHMP Adopts Positive Opinion for Genzyme’s Cerdelga® (eliglustat) Capsules

Nov 21, 2014 - With Orphan Drugs’ Launches Increasing, Payers Need Effective Management (with Table: U.S. Top 20 Most Expensive Drugs)

Nov 21, 2014 - Should you be drinking plant-based waters?

Nov 21, 2014 - Countries vow to combat nutrition

Nov 21, 2014 - Spirulina: Nutrition Facts & Health Benefits

Nov 19, 2014 - Data on Gaucher's Disease Reported by Researchers at Genzyme (Eliglustat, an investigational oral therapy for Gaucher disease type 1: Phase 2 trial...

Nov 19, 2014 - National Association of Clinical Nurse Specialists Announces Task Forces to Address Malnutrition in Hospitalized Patients and Caring for Patients with Chronic Conditions

Nov 18, 2014 - FDA Explains How its New Incentive Program for Rare Pediatric Disease Treatments Works

Nov 18, 2014 - Latest Updates on Amicus Therapeutics, Inc.

Nov 14, 2014 - Gaucher Disease Drugs and Treatment Market

Nov 13, 2014 - Needymeds Honored as 2014 Top-Rated Nonprofit

Nov 13, 2014 - It's Not All Glamour!

Nov 13, 2014 - Medgenics, CHOP enter rare and orphan disease research collaboration

Nov 10, 2014 - Government has a role in ending Ebola and preventing the next deadly disease

Nov 8, 2014 - Why No One On This Planet Has Health Insurance

Nov 7, 2014 - U-M to make $65.6 million from research drug pact

Nov 5, 2014 - Evidence Mounting for Eligustat in Gaucher's Disease

Nov 3, 2014 - Public hospitals urged to hire more genetics counselors to treat rare diseases

Nov 3, 2014 - Greater EU collaboration needed to combat rare diseases

Oct 31, 2014 - Pediatric summit explores growing issue of risk vs. benefits of rare disease drugs

Oct 27, 2014 - Bennett Resnick of West Chester, Pennsylvania says "No Way Gaucher"

Oct 27, 2014 - Ultragenyx Granted Orphan Drug Designation for Triheptanoin for the Treatment of Glucose Transporter Type-1 Deficiency Syndrome

Oct 27, 2014 - Global Genes™ Launches RARE Daily, Innovative Online News Magazine

Oct 27, 2014 - Investment Pros Remain Bullish on Orphans

Oct 25, 2014 - Orphan drugs lead CHMP recommendations

Oct 24, 2014 - Fundraiser held for Conor Toner who has Gaucher disease type 2 11 month old Conor has a rare and fatal brain condition

Oct 24, 2014 - Design Of Micro And Nanoparticles To Improve Treatments For Alzheimer’s and Parkinson’s Diseases

Oct 23, 2014 - Body and Soul

Oct 21, 2014 - A smile worth a crore, but she’s worth it

Oct 20, 2014 - Fundraising for Conor Toner

Oct 15, 2014 - 'Please let son spend final days at home'

Oct 13, 2014 - COMING SUNDAY: Rare disease.

Oct 4, 2014 - LSDSS faces dual challenge of expensive treatment and absence of orphan drug status in India for ERT

Oct 2, 2014 - 'Hannah's Law' One Step Away From State Senate Vote

Sep 30, 2014 - 7th International Conference on Children's Bone Health

Sep 30, 2014 - Gaucher disease: an interview with Dr Clement Olivier, Shire

Sep 19, 2014 - Cycling for Gaucher disease

Sep 19, 2014 - Experts ask India to lead R&D in rare disease drugs

Sep 18, 2014 - Navidea Biopharma (NAVB) Receives Orphan Designation for Lymphoseek in Head and Neck Cancers

Sep 18, 2014 - Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors

Sep 18, 2014 - Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients

Sep 18, 2014 - Lysosomal Storage Diseases Market: Global Industry Analysis and Forecast to 2020 by Persistence Market Research

Sep 15, 2014 - PCORnet CENA Project Launch Spotlight on the National Gaucher Foundation and Joubert Syndrome and Related Disorders Foundation

Sep 11, 2014 - At U-M, 40 Years Of Gaucher Research Rewarded With FDA Approval

Sep 8, 2014 - Announcing the Launch of Expression of Hope III – SUBMISSION PERIOD IS NOW OPEN!

Sep 5, 2014 - The FDA Has Approved How Many Novel New Drugs So Far This Year?

Sep 4, 2014 - Gaucher & Parkinson, Take A Hike!.

Sep 2, 2014 - FDA Clears Taliglucerase Alfa for Kids With Gaucher Disease.

Sep 2, 2014 - New Genzyme pill will cost patients $310,250 a year.